Neurol. praxi. 2011;12(5):359-362

Myasthenia gravis - correlation with influenza vaccination

MUDr.Jana Junkerová1, MUDr.Olga Zapletalová1, MUDr.Jan Živný, Ph.D.2
1 Neurologická klinika FN Ostrava
2 Ústav patologické fyziologie, 1. LF UK, Praha

We present a case of aged married couple with generalized myasthenia gravis (MG). Clinical diagnosis was supported by EMG findings and

evidence of antibody production against acetylcholin receptors. Myasthenia gravis clinically manifested several weeks after vaccination

against influenza and subsequent viral infection with fever in both patients. The failure of immune tolerance and the development of

organ-specific autoimmune disease emerged in polymorbid individuals. We assume that both patients developed MG on the ground of

pre-existing disorders of the immune system (hypothyroidism). Iatrogenic (immunization) or viral infection resulted in the stimulation

of the immune defense response which led to the deregulation of immune tolerance and clinical manifestations of MG. Noticeable is the

close relation between the immunization, viral infection and development of the symptoms in both individuals.

Keywords: myasthenia gravis, vaccinations, viral infection

Published: November 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Junkerová J, Zapletalová O, Živný J. Myasthenia gravis - correlation with influenza vaccination. Neurol. praxi. 2011;12(5):359-362.
Download citation

References

  1. Ambler Z, Bauer J, Bednařík J, Cerman J, Česák T, Ehler E, Eliáš P, Havrdová E, Herman E, Hobza V, Hovorka J, Kadaňka Z, Komárek V, Kuba R, Látr I, Mareš J, Marková J, Marusič P, Marek M, Náhlovský J, Němeček S, Němečková J, Nevšímalová S, Pícha D, Růžička E, Smrčka M, Štouroč P, Urban P, Voháňka S, Vymazal J. Klinická neurologie: část speciální I. Praha: Triton 2010; 707s.
  2. Felsey AR, Treanor JJ, Tornieporth N, Cepellan J, Gorse GJ. Randomized, Double-Blind Controlled Phase 3 Trial Comparing the Immunogenicity of High-Dose and Standard-Dose Influenza Vaccine in Adults 65 Years of Age and Older. The Journal of Infectious Diseases 2009; 200: 172-180. Go to original source... Go to PubMed...
  3. Fujinami RS, von Herrath MG, Christen U, Whitton JL. Molecular mimicry, bystander activation, or viral perzistence: infections and autoimmune disease. Clin. Microbiol. Rev 2006; 19: 80-94. Go to original source... Go to PubMed...
  4. Giraud M, Vandiedonck C, Garchon HJ. Genetic factors in autoimmune myasthenia gravis. Ann N Y Acad Sci 2008; 1132: 180-92. Go to original source... Go to PubMed...
  5. Hohfield R, Toyka KV, Heininger K, Grosse-Wilde H, Kalies I. Autoimmune human T lymphocytes specific for acetylcholine receptor. Nature 1984; 310: 244-6. Go to original source... Go to PubMed...
  6. Keesey JC. Clinical evaluation and management of myasthenia gravis. Muscle Nerve 2004; 29: 484-505. Go to original source... Go to PubMed...
  7. Nath A, Kerman RH, Novak IS, Wolinsky JS. Immune studies in human immunodeficiency virus infection with myasthenia gravis: a case report. Neurology 1990; 40: 581-583. Go to original source... Go to PubMed...
  8. Piťha J, Ambler Z, Bednařík J, Jakubíková M, Kalous K, Seeman P, Schützner J, Špalek P, Tvrdoň J, Voháňka S, Zámečník J. Myasthenia gravis a ostatní poruchy nervosvalového přenosu. Praha: Maxdorf 2010; 367s.
  9. Poussin MA, Goluszko E, Hughes TH, Duchicella SI, Christadoss P. Suppression of experimental autoimmune myasthenia gravis in IL-10 gene-disrupted mice is associated with reduced B cells and serum cytotoxicity on mouse cell line expressing AchR. Journal of Neuroimmunology 2000; 111: 152-160. Go to original source... Go to PubMed...
  10. Sakaguchi S, Wing K and Yamaguchi T. Dynamics of peripheral tolerance and immune regulation mediated by Treg. Eur. J. Immunol. 2009; 39: 2331-2336. Go to original source... Go to PubMed...
  11. Sekiguchi Y, Hara Y, Takahashi M, Hirata Y. Reverse ´see-saw´relationship between Graves´diseaseand myasthenia gravis: clinical and immunological studies. J Med Dent Sci 2005; 52: 43-50. Go to PubMed...
  12. Špalek P. Myasténia gravis - autoimunitné spektrum a imunopatogenetická klasifikácia. Neurológia 2009; 4: 25-30.
  13. Wang ZY, Diethelm-Okita B, Okita DK, Kaminski HJ, Howard JF, Conti-Fine BM. T cell recognition of muscle acetylcholine receptor in ocular myasthenia gravis. Journal of Neuroimmunology 2000; 108: 29-39. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.